May 29, 2019
Takeda CEO Christophe Weber at Ground-Breaking Ceremony in Osaka Takeda Pharmaceutical plans to build a new manufacturing facility for its anticancer agent Leuplin (leuprorelin) at the location of its Osaka plant with costs of some 11 billion yen, it said...read more